Mistrial in federal Vioxx case

Ted has been covering developments in the case against Merck at length over at Point of Law, with occasional contributions from others such as Michael Krauss and me. On the New England Journal of Medicine story of last week, see also Derek Lowe, Dec. 9, and Evan Schaeffer, Dec. 8.

Ted has been covering developments in the case against Merck at length over at Point of Law, with occasional contributions from others such as Michael Krauss and me. On the New England Journal of Medicine story of last week, see also Derek Lowe, Dec. 9, and Evan Schaeffer, Dec. 8.

Comments are closed.